MedPath

"UNMASKING Study" For Atrial Fibrillation Recurrences Typing in Early Postoperative Period

Phase 3
Completed
Conditions
Atrial Fibrillation
Registration Number
NCT01164319
Lead Sponsor
Meshalkin Research Institute of Pathology of Circulation
Brief Summary

The aim of this study is to identify the most appropriate method for managing patients with AF recurrences after the first ablation procedure, through the diagnostic data stored by a subcutaneous AF monitor.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • highly symptomatic patients refractory to at least two antiarrhythmic drugs
  • patients with sustained PAF episodes and/or history of PersAF interrupted with cardioversion.
Exclusion Criteria
  • congestive heart failure
  • ejection fraction <35%
  • left atrial diameter >60 mm
  • previous ablation procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Freedom from atrial fibrillation or atrial flutter/tachycardia in Group 4 vs Group 312 months
Secondary Outcome Measures
NameTimeMethod
Freedom from AF in each group and the comparison of any group to each other12 months

Trial Locations

Locations (1)

State Research Institute of CIrculation Pathology

🇷🇺

Novosibirsk, Russian Federation

State Research Institute of CIrculation Pathology
🇷🇺Novosibirsk, Russian Federation

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.